Belcher Must Cover Hospira's Legal Fees In Patent Fight
A Delaware federal judge has ordered Belcher Pharmaceuticals to foot the bill for Pfizer unit Hospira in Belcher's patent infringement suit over epinephrine injector Abboject, finding that the accuser's antics during...To view the full article, register now.
Already a subscriber? Click here to view full article